Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph M Herman

Showing results (71-80 of 316) with videos related to

Pageof 32
Sort By:
Current Oncology (Toronto, Ont.)|January 20, 2022
Upfront Chemotherapy Followed by Stereotactic Body Radiation Therapy with or without Surgery in Older Patients with Localized Pancreatic Cancer: A Single Institution Experience and Review of the LiteratureAbhinav V Reddy, Shuchi Sehgal, Colin S Hill, et al.
Journal of Oncology Practice|May 2, 2013
Accuracy of marketing claims by providers of stereotactic radiation therapyAmol K Narang, Edwin Lam, Martin A Makary, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 3, 2013
Cadmium exposure and liver disease among US adultsOmar Hyder, Michael Chung, David Cosgrove, et al.
Translational Oncology|May 20, 2014
Radiosensitization of Pancreatic Cancer Cells In Vitro and In Vivo through Poly (ADP-ribose) Polymerase Inhibition with ABT-888Richard Tuli, Andrew J Surmak, Juvenal Reyes, et al.
Journal of Gastrointestinal Oncology|March 14, 2022
High neutrophil-to-lymphocyte ratio following stereotactic body radiation therapy is associated with poor clinical outcomes in patients with borderline resectable and locally advanced pancreatic cancerAbhinav V Reddy, Colin S Hill, Shuchi Sehgal, et al.
Surgery|July 30, 2013
Provider versus patient factors impacting hospital length of stay after pancreaticoduodenectomyEric B Schneider, Omar Hyder, Christopher L Wolfgang, et al.
AJR. American Journal of Roentgenology|April 24, 2015
Prognostic Value of FDG PET/CT-Derived Parameters in Pancreatic Adenocarcinoma at Initial PET/CT StagingAlin Chirindel, Krishna C Alluri, Muhammad A Chaudhry, et al.
Journal of Gastrointestinal Oncology|July 15, 2022
Stereotactic body radiation therapy for the treatment of locally recurrent pancreatic cancer after surgical resectionAbhinav V Reddy, Colin S Hill, Shuchi Sehgal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 18, 2011
Increased organ sparing using shape-based treatment plan optimization for intensity modulated radiation therapy of pancreatic adenocarcinomaSteven F Petit, Binbin Wu, Michael Kazhdan, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 6, 2019
Exploring the patient experience of locally advanced or metastatic pancreatic cancer to inform patient-reported outcomes assessmentJoseph M Herman, Helen Kitchen, Arnold Degboe, et al.
Pageof 32

Showing results (71-80 of 316) with videos related to

Sort By:
Pageof 32
Current Oncology (Toronto, Ont.)|January 20, 2022
Upfront Chemotherapy Followed by Stereotactic Body Radiation Therapy with or without Surgery in Older Patients with Localized Pancreatic Cancer: A Single Institution Experience and Review of the LiteratureAbhinav V Reddy, Shuchi Sehgal, Colin S Hill, et al.
Journal of Oncology Practice|May 2, 2013
Accuracy of marketing claims by providers of stereotactic radiation therapyAmol K Narang, Edwin Lam, Martin A Makary, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 3, 2013
Cadmium exposure and liver disease among US adultsOmar Hyder, Michael Chung, David Cosgrove, et al.
Translational Oncology|May 20, 2014
Radiosensitization of Pancreatic Cancer Cells In Vitro and In Vivo through Poly (ADP-ribose) Polymerase Inhibition with ABT-888Richard Tuli, Andrew J Surmak, Juvenal Reyes, et al.
Journal of Gastrointestinal Oncology|March 14, 2022
High neutrophil-to-lymphocyte ratio following stereotactic body radiation therapy is associated with poor clinical outcomes in patients with borderline resectable and locally advanced pancreatic cancerAbhinav V Reddy, Colin S Hill, Shuchi Sehgal, et al.
Surgery|July 30, 2013
Provider versus patient factors impacting hospital length of stay after pancreaticoduodenectomyEric B Schneider, Omar Hyder, Christopher L Wolfgang, et al.
AJR. American Journal of Roentgenology|April 24, 2015
Prognostic Value of FDG PET/CT-Derived Parameters in Pancreatic Adenocarcinoma at Initial PET/CT StagingAlin Chirindel, Krishna C Alluri, Muhammad A Chaudhry, et al.
Journal of Gastrointestinal Oncology|July 15, 2022
Stereotactic body radiation therapy for the treatment of locally recurrent pancreatic cancer after surgical resectionAbhinav V Reddy, Colin S Hill, Shuchi Sehgal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 18, 2011
Increased organ sparing using shape-based treatment plan optimization for intensity modulated radiation therapy of pancreatic adenocarcinomaSteven F Petit, Binbin Wu, Michael Kazhdan, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 6, 2019
Exploring the patient experience of locally advanced or metastatic pancreatic cancer to inform patient-reported outcomes assessmentJoseph M Herman, Helen Kitchen, Arnold Degboe, et al.
Pageof 32